Literature DB >> 15280037

Identification of ubiquitin-interacting proteins in purified polyglutamine aggregates.

Hiroshi Doi1, Kenichi Mitsui, Masaru Kurosawa, Yoko Machida, Yoshiyuki Kuroiwa, Nobuyuki Nukina.   

Abstract

Nuclear aggregates of enhanced green fluorescent protein and nuclear localization signal-fused truncated N-terminal huntingtin containing 150 repeats of glutamine residue were purified from ecdysine-inducible mutant neuro2A cell line by sequential extraction of nuclear soluble proteins. To analyze the aggregate-interacting proteins, we subjected the nuclear aggregates to high performance liquid chromatography-mass spectrometry analysis. The resulting data revealed the presence of three new putative aggregate-interacting proteins: ubiquilin 1, ubiquilin 2 and Tollip. These proteins also associated with neuronal intranuclear inclusions in a mouse model of Huntington disease (HD). These aggregate-interacting proteins contain ubiquitin-interacting motifs, suggesting that they are recruited to the aggregates where they may lose their normal function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15280037     DOI: 10.1016/j.febslet.2004.06.077

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  46 in total

1.  Involvement of ubiquilin-1 transcript variants in protein degradation and accumulation.

Authors:  Annakaisa Haapasalo; Jayashree Viswanathan; Kaisa Ma Kurkinen; Lars Bertram; Hilkka Soininen; Nico P Dantuma; Rudolph E Tanzi; Mikko Hiltunen
Journal:  Commun Integr Biol       Date:  2011-07-01

2.  Exome sequencing reveals a homozygous SYT14 mutation in adult-onset, autosomal-recessive spinocerebellar ataxia with psychomotor retardation.

Authors:  Hiroshi Doi; Kunihiro Yoshida; Takao Yasuda; Mitsunori Fukuda; Yoko Fukuda; Hiroshi Morita; Shu-ichi Ikeda; Rumiko Kato; Yoshinori Tsurusaki; Noriko Miyake; Hirotomo Saitsu; Haruya Sakai; Satoko Miyatake; Masaaki Shiina; Nobuyuki Nukina; Shigeru Koyano; Shoji Tsuji; Yoshiyuki Kuroiwa; Naomichi Matsumoto
Journal:  Am J Hum Genet       Date:  2011-08-12       Impact factor: 11.025

3.  IRBIT, an inositol 1,4,5-trisphosphate receptor-binding protein, specifically binds to and activates pancreas-type Na+/HCO3- cotransporter 1 (pNBC1).

Authors:  Kyoko Shirakabe; Giuseppina Priori; Hideomi Yamada; Hideaki Ando; Shoko Horita; Toshiro Fujita; Ichiro Fujimoto; Akihiro Mizutani; George Seki; Katsuhiko Mikoshiba
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-12       Impact factor: 11.205

4.  Ubiquilin interacts and enhances the degradation of expanded-polyglutamine proteins.

Authors:  Hongmin Wang; Mervyn J Monteiro
Journal:  Biochem Biophys Res Commun       Date:  2007-06-25       Impact factor: 3.575

5.  Characterization of proteins associated with polyglutamine aggregates: a novel approach towards isolation of aggregates from protein conformation disorders.

Authors:  Yan Wang; Anatoli B Meriin; Catherine E Costello; Michael Y Sherman
Journal:  Prion       Date:  2007-04-16       Impact factor: 3.931

6.  Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability.

Authors:  Antonella Caccamo; Smita Majumder; Janice J Deng; Yidong Bai; Fiona B Thornton; Salvatore Oddo
Journal:  J Biol Chem       Date:  2009-08-03       Impact factor: 5.157

7.  Dimerization of ubiquilin is dependent upon the central region of the protein: evidence that the monomer, but not the dimer, is involved in binding presenilins.

Authors:  Diana L Ford; Mervyn J Monteiro
Journal:  Biochem J       Date:  2006-11-01       Impact factor: 3.857

8.  Ubiquilin-1 protects cells from oxidative stress and ischemic stroke caused tissue injury in mice.

Authors:  Yanying Liu; Lanhai Lü; Casey L Hettinger; Gaofeng Dong; Dong Zhang; Khosrow Rezvani; Xuejun Wang; Hongmin Wang
Journal:  J Neurosci       Date:  2014-02-19       Impact factor: 6.167

Review 9.  A novel therapeutic strategy for polyglutamine diseases by stabilizing aggregation-prone proteins with small molecules.

Authors:  Motomasa Tanaka; Yoko Machida; Nobuyuki Nukina
Journal:  J Mol Med (Berl)       Date:  2005-03-10       Impact factor: 4.599

10.  Mutant Huntingtin reduces HSP70 expression through the sequestration of NF-Y transcription factor.

Authors:  Tomoyuki Yamanaka; Haruko Miyazaki; Fumitaka Oyama; Masaru Kurosawa; Chika Washizu; Hiroshi Doi; Nobuyuki Nukina
Journal:  EMBO J       Date:  2008-02-21       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.